Interestingly, the GEPIA assay revealed that both GPX4 and AIFM2 expression levels in the GTEx database of healthy people were higher than those of AML patients in the TCGA database (Figure 2B–2E). The gene discussed is GPX4; the disease is acute myeloid leukemia.